XEME Biopharma, Inc. — Form D

XEME Biopharma, Inc. of LOMBARD, IL, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-04. The offering totals $10.0M. Industry: Pharmaceuticals.

Offering

• Filed: 2017-04-04
• Form: D
• Accession: 0001696915-17-000001
• Industry: Pharmaceuticals
• Exemptions: 06c
• Total offering: $10.0M
• Remaining: $10.0M
• Minimum investment: $25K
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-284014

Issuer

• Name: XEME Biopharma, Inc.
• CIK: 0001696915
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 1120 N. DUPAGE AVENUE, LOMBARD, IL, 60148
• Phone: 18447099363

Officers, directors & promoters (7)

More

• CIK 1696915 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search